Home
Alerts
Search
Watchlists
Products
Vanta Bioscience Ltd
VANTABIO
BSE
₹ 15.15
Last Updated:
02 Apr '26, 3:59 PM
Industry:
Miscellaneous
Vanta Bioscience Ltd
VANTABIO
BSE
₹ 15.15
02 Apr '26, 3:59 PM
Industry
Miscellaneous
6M
Price
Charts
Documents
Quick Ratios
Edit Ratios
Mkt Cap
Market Capitalization
₹11Cr
Close
Close Price
₹15.15
Industry
Industry
Miscellaneous
PE
Price To Earnings
PS
Price To Sales
8.76
Revenue
Revenue
₹1Cr
Rev Gr TTM
Revenue Growth TTM
-73.14%
PAT Gr TTM
PAT Growth TTM
17.66%
Quarterly Results
Consolidated
Standalone
Numbers
Percentage
| Quarter | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7 | 5 | 5 | 5 | 4 | 3 | 3 | 6 | 4 | 1 | 1 | 0 | |
Growth YoY Revenue Growth YoY% | 5.4 | -28.0 | -30.1 | 1.9 | -9.4 | -47.6 | -19.9 | 119.2 | 2.9 | -83.3 | -73.8 | -70.9 |
| 5 | 4 | 3 | 4 | 2 | 3 | 5 | 4 | 4 | 1 | 5 | 1 | |
| 2 | 2 | 2 | 1 | 2 | -1 | -2 | 2 | -1 | 0 | -4 | 0 | |
OPM OPM% | 32.2 | 33.7 | 45.4 | 27.7 | 45.9 | -19.5 | -53.6 | 33.5 | -21.1 | -36.9 | -417.2 | -123.3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 3 | 3 | 2 | 2 | 1 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 1 |
PBT PBTCr | 1 | 1 | 1 | 0 | 1 | -3 | -5 | -1 | -4 | -2 | -6 | -1 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 0 | 0 | 0 | 0 | 0 | -3 | -4 | -1 | -2 | -2 | -3 | -2 | |
Growth YoY PAT Growth YoY% | 15.0 | -88.9 | -15.2 | -66.7 | -82.0 | -12,900.0 | -5,700.0 | 78.9 | 54.6 | -283.3 | -52.3 | 12.1 |
NPM NPM% | 6.8 | 1.1 | 8.2 | 0.4 | 1.6 | -90.8 | -113.6 | -8.7 | -50.1 | -201.0 | -291.4 | -606.7 |
| 0.7 | 0.1 | 0.6 | 0.0 | 0.1 | -4.1 | -6.2 | -0.8 | -2.8 | -3.3 | -4.3 | -2.6 |
Profit & Loss
Consolidated
Standalone
Numbers
Percentage
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 12 | 14 | 10 | 10 | 6 | 10 | 2 | 1 |
Growth Revenue Growth% | 13.8 | -29.0 | -3.5 | -35.2 | 54.9 | -79.8 | -37.4 | |
| 9 | 10 | 6 | 6 | 9 | 8 | 6 | 5 | |
| 3 | 4 | 4 | 3 | -2 | 1 | -4 | -4 | |
OPM OPM% | 26.4 | 30.9 | 39.3 | 35.8 | -38.1 | 13.5 | -216.8 | -345.5 |
| 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 2 | 6 | 6 | 4 | 3 |
Depreciation DepreciationCr | 1 | 1 | 1 | 1 | 3 | 5 | 4 | 3 |
PBT PBTCr | 1 | 1 | 1 | 0 | -10 | -9 | -13 | -7 |
| 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | |
PAT PATCr | 1 | 1 | 0 | 0 | -10 | -9 | -13 | -5 |
Growth PAT Growth% | 45.1 | -55.7 | -70.0 | -7,855.7 | 17.6 | -54.4 | 65.9 | |
NPM NPM% | 5.6 | 7.2 | 4.5 | 1.4 | -166.4 | -88.5 | -676.8 | -368.3 |
| 1.2 | 1.6 | 0.7 | 0.1 | -10.3 | -3.7 | -7.6 | -6.8 |
Balance Sheet
Consolidated
Standalone
Numbers
Percentage
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Reserves ReservesCr | 16 | 17 | 18 | 18 | 11 | 9 | 4 |
| 3 | 10 | 15 | 18 | 18 | 23 | 27 | |
| 13 | 14 | 29 | 34 | 48 | 50 | 56 | |
| 39 | 49 | 70 | 81 | 85 | 85 | 86 | |
| 17 | 20 | 20 | 15 | 15 | 17 | 15 | |
| 22 | 29 | 50 | 67 | 69 | 68 | 71 | |
| 39 | 49 | 70 | 81 | 85 | 85 | 86 |
Cash Flow
Consolidated
Standalone
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
| -1 | 2 | 7 | 5 | -1 | 3 | -2 | |
| -6 | -7 | -22 | -17 | -6 | -3 | -7 | |
| 10 | 2 | 18 | 10 | 6 | 1 | 9 | |
Net Cash Flow Net Cash FlowCr | 3 | -3 | 2 | -2 | 0 | 0 | 0 |
Free Cash Flow Free Cash FlowCr | -4 | 2 | 6 | 5 | -29 | -1 | |
CFO To PAT CFO To PAT% | -148.7 | 231.1 | 1,555.0 | 3,919.7 | 6.0 | -31.2 | 18.1 |
CFO To EBITDA CFO To EBITDA% | -31.7 | 53.6 | 176.7 | 152.2 | 26.2 | 204.4 | 56.6 |
Ratios
Consolidated
Standalone
| Financial Year | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 97 | 57 | 103 | 69 | 36 | 40 | 14 |
Price To Earnings Price To Earnings | 137.8 | 57.2 | 229.6 | 784.6 | 0.0 | 0.0 | 0.0 |
Price To Sales Price To Sales | 7.8 | 4.1 | 10.3 | 7.2 | 5.8 | 4.2 | 7.1 |
Price To Book Price To Book | 4.3 | 2.5 | 4.3 | 2.9 | 2.1 | 2.7 | 1.3 |
EV To EBITDA EV To EBITDA | 32.2 | 16.7 | 33.5 | 31.5 | -39.0 | 77.1 | -19.7 |
GPM GPM% | 89.4 | 91.7 | 91.8 | 92.8 | 84.9 | 92.6 | 32.0 |
OPM OPM% | 26.4 | 30.9 | 39.3 | 35.8 | -38.1 | 13.5 | -216.8 |
NPM NPM% | 5.6 | 7.2 | 4.5 | 1.4 | -166.4 | -88.5 | -676.8 |
ROCE ROCE% | 8.1 | 8.4 | 4.9 | 4.0 | -5.9 | -4.0 | -10.6 |
ROE ROE% | 3.1 | 4.3 | 1.9 | 0.6 | -59.6 | -56.6 | -127.5 |
ROA ROA% | 1.8 | 2.1 | 0.6 | 0.2 | -12.3 | -10.1 | -15.5 |